These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23636373)

  • 1. Targeted drugs to tackle hepatitis C.
    Mole B
    Nature; 2013 May; 497(7447):18-9. PubMed ID: 23636373
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.
    Cohen J
    Science; 2013 Dec; 342(6164):1302-3. PubMed ID: 24337268
    [No Abstract]   [Full Text] [Related]  

  • 3. Sofosbuvir (Sovaldi) for hepatitis C virus.
    Lomberk M; Klibanov OM
    Nurse Pract; 2015 Sep; 40(9):16-9. PubMed ID: 26274882
    [No Abstract]   [Full Text] [Related]  

  • 4. Trials wrap on interferon-free hepatitis C regimen.
    Dalzell MD
    Manag Care; 2013 Apr; 22(4):41-2. PubMed ID: 23678562
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C.
    Mariño Z; van Bömmel F; Forns X; Berg T
    Gut; 2014 Feb; 63(2):207-15. PubMed ID: 24253934
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approvals usher in the post-interferon era in HCV.
    Sheridan C
    Nat Biotechnol; 2014 Jan; 32(1):3-5. PubMed ID: 24406908
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C.
    Chan J
    Dis Mon; 2014 May; 60(5):201-12. PubMed ID: 24863270
    [No Abstract]   [Full Text] [Related]  

  • 8. All-oral HCV therapies near approval.
    Tse MT
    Nat Rev Drug Discov; 2013 Jun; 12(6):409-11. PubMed ID: 23722330
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C virus therapies.
    Smith RE
    Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR.
    Martel-Laferrière V; Dieterich DT
    Clin Liver Dis; 2013 Feb; 17(1):93-103. PubMed ID: 23177285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.
    Toniutto P; Fabris C; Bitetto D; Fornasiere E; Rapetti R; Pirisi M
    Curr Opin Investig Drugs; 2007 Feb; 8(2):150-8. PubMed ID: 17328231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A
    Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
    [No Abstract]   [Full Text] [Related]  

  • 13. Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005.
    Writing Committee of the Consensus Panel
    Dig Liver Dis; 2006 Jul; 38(7):445-51. PubMed ID: 16735144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 15. Lawsuit seeks access to data from hepatitis C drug trial.
    McCarthy M
    BMJ; 2015 Jun; 350():h3564. PubMed ID: 26126508
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of diastereomerically pure nucleotide phosphoramidates.
    Ross BS; Reddy PG; Zhang HR; Rachakonda S; Sofia MJ
    J Org Chem; 2011 Oct; 76(20):8311-9. PubMed ID: 21916475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The uses and abuses of cost-effectiveness analysis.
    Goozner M
    Mod Healthc; 2014 Aug; 44(32):26. PubMed ID: 25318245
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dare to refuse the exorbitant price of Sovaldi!
    Prescrire Int; 2014 Nov; 23(154):278. PubMed ID: 25954802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.